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Abstract
Adenomatous Polyposis Coli (APC) is a tumor suppressor gene product involved in colon cancer. APC is a large multidomain
molecule of 2843 amino acid residues and connects cell-cell adhesion, the F-actin/microtubule cytoskeleton and the
nucleus. Here we show that Cdc42 interacts directly with the first three armadillo repeats of APC by yeast two-hybrid
screens. We confirm the Cdc42-APC interaction using pulldown assays in vitro and FRET assays in vivo. Interestingly, Cdc42
interacts with APC at leading edge sites where F-actin is enriched. In contrast, Cdc42 interacts with the truncated mutant
APC
1–1638 in cellular puncta associated with the golgi-lysozome pathway in transfected CHO cells. In HCT116 and SW480
cells, Cdc42 induces the relocalization of endogenous APC and the mutant APC
1–1338 to the plasma membrane and cellular
puncta, respectively. Taken together, these data indicate that the Cdc42-APC interaction induces localization of both APC
and mutant APC and may thus play a direct role in the functions of these proteins.
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Introduction
Adenomatous Polyposis Coli (APC) is a tumor suppressor gene
product involved in cellular processes including Wnt signaling, cell
growth, cell fate determination and cell migration. APC is a
multidomain scaffold protein of 2843 amino acid (aa) residues
linking the nucleus to cell surface events through associations with
the cytoskeleton [1]. The APC N-terminal is a region that contains
seven armadillo repeats [2] through which it binds KAP3 (kinesin-
associated protein 3), Asef (Cdc42/Rac-specific guanine nucleo-
tide exchange factor) and IQGAP1 (IQ motif containing GTPase
activating protein 1) [3–5]. The central domain has a mutation
cluster region that binds axin and beta-catenin/alpha-catenin
[2,6,7]. The C-terminal region of APC consists of positively
charged amino acid residues responsible for binding microtubules
and EB1 (end-binding protein 1). The binding site for a PDZ
domain [8] is the last domain of the C-terminus.
Mutation of APC causes Familial Adenomatous Polyposis, an
inherited form of colon cancer. The most frequently found
truncations are divided into two groups. Type I truncations, which
are the most common type among sporadic colorectal tumors,
retain the N-terminal nuclear export signal (n-NES) but lack the
C-terminal NES (c-NES). Type II APC truncations retain the n-
NES as well as the 59-most c-NES. Interestingly, type II APC
truncations show the APC protein to be excluded from nuclei [9].
Truncations lacking the C-terminal domains of APC are the ones
associated with tumorigenesis. Germline mutations occurring at
codons 1061 and 1309 account for a third of the mutations. Apart
from these hotspots, germline mutations in APC are spread fairly
uniformly between codons 200 and 1600 but rarely occur beyond
codon 1600. Truncated APC proteins found in colorectal tumors
seldom retain the basic domain [10,11].
Tumor formation and metastasis involve coordinated changes
in the actin and microtubule cytoskeletons [12,13]. Overexpres-
sion of Rho GTPases is likely to increase tumor invasiveness
through effects of cell migration and matrix degradation [14,15].
The small GTP-binding protein Cdc42 regulates cell morphology
and polarity signals by interacting directly with a number of
protein effectors. For example, Cdc42 regulates the localization
and function of IRSp53 (insulin receptor substrate protein 53 kD)
leading to complex formation with N-WASP (neural Wiskott-
Aldrich syndrome protein), Mena (mammalian enabled), and Eps8
(EGF receptor kinase substrate 8) to induce filopodium formation
[16–18]. Investigation of protein complexes that link actin,
microtubules and APC is likely to reveal important elements of
tumor formation. The Cdc42 effector IQGAP1 interacts directly
with APC and may be responsible for actin accumulation at the
leading edge and directional migration [5]. Cdc42 controls cell
polarity through the spatial regulation of GSK-3b (glycogen
synthase kinase-3b) phosphorylation of APC [19]. APC has been
found to interact with Asef with a potential consequence for cell
migration [20].
In the present study, we carried out a yeast two-hybrid (Y2H)
screen of nine cDNA libraries using Cdc42 as a bait, which yielded
10 novel interactors including a 431 aa fragment of APC that
contains the first three armadillo repeats. The Cdc42 interaction
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pulldowns, FRET [18] and fluorescence lifetime imaging micros-
copy (FLIM; [21]). Cdc42 was also found to interact directly with
both full-length APC and a truncation mutant APC
1–1638, which is
implicated in colon cancer. In CHO cells Cdc42 interacts with
APC at the leading edge and with APC
1–1638 in cellular puncta.
Interestingly, Cdc42 induced the relocalization of APC
1–1638 from
cellular puncta to the late endocytic pathway. In contrast, Cdc42
induces relocalization of full-length APC to the leading edge with
F-actin. Furthermore, Cdc42 induced the relocalization of
endogenous APC and APC
1–1338 (the most commonly used
mutant for endogenous studies) to the leading edge and cell
puncta in HCT116 and SW480 cells, respectively. Taken together,
these data suggest that Cdc42 may play an important physiological
role in the function of APC and APC mutants by binding these
proteins directly and influencing their cellular localization.
Materials and Methods
Plasmids
mRFP is a kind gift from Prof. Roger Y. Tsien (University of
California, San Diego). GFP-Cdc42V12, HA-Cdc42 and GFP-
Cdc42N17 were generated by subcloning the respective inserts
into the pXJ40 vector. mRFP-Cdc42V12 and mRFP-Cdc42N17
were created by subcloning the respective gene into the pXJ40-
mRFP vector in between the BamHI and BglII restriction sites.
mRFP-APC
222–653 was made by inserting the amino acid
sequences of APC
222–653 into the pXJ40-mRFP vector in between
the BamHI and NotI restriction sites. APC
222–452 and APC
453–653
were made by inserting the corresponding amino acid sequences of
APC into the pXJ40-mRFP vector in between the BamHI and
NotI restriction sites (generously given by Yong Hwee Foo).
mRFP-GFP tandem fusion was made by inserting GFP between
the BamHI and NotI sites in the pXJ40-mRFP vector. mRFP-
SBP-Cdc42V12 and mRFP-SBP-GFP were made by inserting
streptavidin binding protein (SBP) into the BamHI site. Full-length
GFP-APC and GFP-APC
1–1638 were a kind gift from Dr. Maree
Faux (Ludwig Institute for Cancer Research, Australia). All
restriction enzymes were obtained from NEB Biolabs.
Yeast two-hybrid screening
Matchmaker
TM pre-transformed human cDNA libraries were
screened using the Matchmaker
TM GAL4 two-hybrid system 3
according to the manufacturer’s protocol (Clontech). Briefly, the
bait protein Cdc42Q61L/C189S cDNA was cloned into the
pAS2-1 vector and the resulting construct transformed into
AH109 strain yeast cells. Transformants were selected for growth
on synthetic dropout (SD) medium lacking tryptophan, and mated
with Y187 strain yeast cells pretransformed with human cDNA
libraries. Putative positive bait-prey interactions in the resulting
diploids formed were identified by growth on quadruple dropout
(QDO; SD medium lacking adenine, histidine, leucine and
tryptophan) medium. Yeast plasmid DNA was extracted from
clones that grew on QDO medium, electroporated into Escherichia
coli KC8 strain cells, and the bacterial plasmids isolated and
sequenced. Sequences obtained were analyzed by BLAST to
determine the identity of the putative Cdc42-binding proteins.
Complementation assays to confirm the putative interactions in a
clean yeast background were done by transforming bait and prey
plasmids into AH109 and Y187 yeast strains respectively, and
mating the transformants obtained (identified by their ability to
grow on tryptophan- or leucine-deficient SD medium). The b-
galactosidase assay was used to verify positive bait-prey interaction
in diploids that survived on QDO medium, as well as lack of
interaction in diploids that grew on SD medium lacking
tryptophan and leucine but not on QDO. All yeast and bacterial
strains, vectors and cDNA libraries were from Clontech, and all
yeast culture media components were from Clontech and Difco
and prepared according to the Matchmaker
TM GAL4 two-hybrid
system yeast protocols handbook (Clontech).
Tissue Culture
CHO cells were obtained from ATCC (Manassas,VA) and
grown in 75 cm
2 tissue culture flasks up to 90% confluency in
complete growth medium, in 16F-12 Nutrient mixture (Kaighn’s
modification) media containing 10% fetal bovine serum (FBS) and
1% antibiotics (penicillin and streptomycin). All tissue culture
reagents were obtained from Invitrogen (Singapore). CHO cell
transfections were carried out by seeding the cells in a six-well
tissue culture plate containing 18618 mm pre-washed sterilized
glass coverslips at 1.5610
5 cells/well one day before transfection.
The seeded cells were transfected using Fugene6 reagent (Roche
Applied Bioscience) with 0.5–1 mg of plasmid DNA. HCT116 and
SW480 colon cancer cells were a kind gift from Dr. Haihe Wang
(Institute of Molecular and Cell Biology, Singapore). HCT116 and
SW480 cells were maintained in RPMI medium and Lipofecta-
mine2000 (Invitrogen) transfection reagent was used to transfect
both colon cancer cell lines.
Co-immunoprecipitation assay for endogenous APC in
SW480 cells
cDNA encoding mRFP-SBP-GFP (negative control) and
mRFP-SBP-Cdc42V12 (experiment) were separately transfected
into SW480 cells and left to express for 24 h. Cells were then lysed
using 20 mM HEPES pH 7.3, 1% Triton X-100, 100 mM NaCl,
20 mM MgCl2, 1 mM Dithiothreitol, 1 mM sodium orthovana-
date, 1 mM phenylmethylsulfonyl fluoride and complete protease
inhibitor mix (Roche). The SBP tag present within the fusion
protein enabled their pulldown using streptavidin-sepharose beads,
followed by washing with lysis buffer, elution by boiling in SDS
sample buffer and resolution on a 6% SDS-PAGE gel. Protein
transfer onto PVDF membranes was mediated by a semi-dry
transfer apparatus using transfer buffer of 48 mM Tris base,
39 mM glycine, 0.37% SDS and 5% methanol overnight at 4uC,
with a constant current of 50 mA and voltage limit of 15 V. The
blots were analyzed for the presence of APC with Ab-5 antibody
(Calbiochem, 1:100) and subsequently stripped and reprobed with
streptavidin-HRP antibody (1:1000) to assess the amounts of
mRFP-SBP-GFP and mRFP-SBP-Cdc42V12.
AP-FRET measurement
Acceptor photobleaching-FRET (AP-FRET) was measured as
described in [18] by making necessary settings in a Zeiss LSM 510
confocal microscope with a C-Apochromat 6361.2 W objective.
Briefly, the transfected GFP/mRFP fusion proteins (as described
earlier) were washed 24 h after transfection with 16 PBS three
times and fixed with 4% paraformaldehyde (Sigma-Aldrich) for
15 min. The fixed coverslips were mounted on glass slides using
Hydromount (National Diagnostics). The mounted cells were
excited using 488 and 561 nm laser lines as excitation sources, by
selecting the 405/488/561 dichroic mirror and the 490/565
secondary dichroic mirrors for GFP and mRFP emission
respectively. The emission was monitored by selecting GFP (BP
505–550) and Red (LP 575) emission filters to record the
fluorescence intensity. Region of interest (ROI) was selected and
photobleached using 70% of 561 nm laser power by selecting 50
iterations. The increase in GFP fluorescence intensity followed by
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efficiency (%FE) was calculated using the change in background
subtracted fluorescence intensity as 1006[(post-bleach intensity)-
(pre-bleach intensity) / (post-bleach intensity)]. Average AP-FRET
value was obtained from 7–10 cells and all experiments were
repeated three times. In order to verify that the increase in GFP
intensity was not due to an artifact we obtained the Pearson
product moment correlation coefficient (CC) r, a dimensionless
index that ranges from 21.0 to 1.0 inclusive, which reflects the
extent of a linear relationship between the two fluorescence
intensity data of GFP and mRFP on acceptor bleaching.
FLIM-FRET measurement
The frequency domain FLIM experiments were performed with
the LIFA system (Lambert Instruments, The Netherlands) on an
inverted widefield fluorescence microscope (Olympus IX71,
Center Valley, PA) with a 6061.35 oil immersion objective [21].
The excitation source was a 4 mW 470 nm LED. The emission
was collected with a 490–550 nm GFP filter. FITC was used as a
lifetime reference with a set lifetime of 4.0 ns. Twelve phase and
modulation shifted images were taken and fitted with a sinus
function using software supplied by the manufacturer. The phase
shifted intensity data was used for lifetime calculation. Transiently
transfected and fixed CHO cells (as described above) were used to
obtain the FLIM image. GFP-fusions of the respective interacting
partners (donor alone) were used to obtain the control lifetime.
The percentage FLIM-FRET efficiency was calculated as
FRET=1006[12(lifetime of donor with FRET/lifetime of donor
without FRET)]. Several ROI were drawn on the images (7–10
cells) and the average lifetime and standard deviation calculated.
All experiments were repeated three times.
Colocalization analysis
For colocalization analysis we used either the Zeiss 510 or
Olympus FV1000 microscope. Fluorescence images of fixed cells
were obtained in either two channel or three channel settings. All
images were obtained sequentially with a constant offset and
pinhole setting in all channels. Colocalization analysis was carried
out using Zeiss or Olympus software. CHO cells were transfected
with GFP-APC alone or together with HA-Cdc42V12 or mRFP-
Cdc42V12 and fixed as described earlier. Cells coexpressing GFP-
APC with or without HA-Cdc4242 or HA-Cdc42N17 were
permeabilized with 0.1% Triton X-100 in PBS for 5 min. Cells
were blocked with 3% BSA for 30 min at room temperature and
incubated with anti-HA mouse monoclonal primary antibody
(1:100) in blocking solution at room temperature for 60 min. Cells
were further washed three times with PBS and then incubated
with Alexa 405 antibody (1:200) along with diluted (1:50) TRITC-
labeled phalloidin (Molecular Probes) at room temperature for
60 min and washed three times with PBS. Cells expressing mRFP-
Cdc42V12 were treated with FITC-labeled phalloidin (Molecular
Probes) at room temperature for 5 min. The cells were then
mounted as described earlier and visualized using confocal
fluorescence microscopy.
Immunofluorescence analysis
(a) For golgi, lysozomes and microtubules. CHO cells
transiently transfected with respective plasmids were fixed and
immunostained as described earlier, using the following primary
antibodies; anti-Lamp1 (goat polyclonal, 1:100, Santa Cruz) for
lysozome, anti-HA (mouse monoclonal, Millipore) for HA-
Cdc42V12 or HA-Cdc42N17, GM130 (mouse monoclonal, BD)
for golgi and anti a-tubulin (mouse monoclonal, 1:500, Sigma) for
microtubules, followed by incubation with the respective
secondary antibodies (Molecular Probes) at 1:200 dilution, anti-
mouse Alexa 405 and anti-goat Cy5 for lysozome-Cdc42V12
colocalization, anti-mouse Alexa 405 for golgi and anti-mouse
Alexa 568 for microtubules.
(b) Endogenous APC detection. HCT116 and SW480 cells,
either untransfected or transfected with mRFP-Cdc42V12 or
Cdc42N17 (alone or coexpressed with GFP-actin), were fixed and
blocked as described previously. Endogenous APC was stained as
described earlier using primary antibodies targeting mouse APC
(ab-2 for HCT116 cells and ab-5 for SW480 cells; 1:50
Calbiochem) followed by incubation with anti-mouse Alexa 488
secondary antibody (1:200, Molecular Probes). For GSK-3b
inhibitor studies, HCT116 cells transfected with mRFP-
Cdc42V12 were treated with 10 mM cell-permeable PKCf–
specific pseudosubstrate (Calbiochem) for 1 h at 37uC, followed
by APC immunostaining.
Results
Cdc42 interacts with APC
222–653
Y2H screening is an in vitro genetic approach to identifying
binding partners from a library of polypeptides. We used the
GAL4 Y2H system to identify protein partners of Cdc42. Human
cDNA libraries were screened using a double mutant form of
Cdc42 (Cdc42Q61L/C189S) as bait. The Q61L and V12 both
mutations of Cdc42 render the protein GTPase-deficient, thus
increasing affinity for effector proteins, which interact only with
the active GTP-bound form of Cdc42. This also enables the
exclusion of GEFs and GDIs, which interact with the inactive
GDP-bound form of Cdc42. The C189S mutation overcomes the
lethal effects of the Q61L mutation by disrupting the isoprenyla-
tion site in Cdc42, preventing membrane localization of the
protein and making it biologically inactive. This mutation also
favours the localization of the bait protein to the nucleus, which is
essential for the Y2H system to work.
Nine human cDNA libraries (brain, fetal brain, bone marrow,
heart, liver, kidney, ovary, testis and 11-day embryo) were
screened, and putative bait-prey interactions gave rise to yeast
clones that survived on QDO medium. pACT2 plasmids were
isolated from 325 of these clones and their sequences determined
and matched against entries in the NCBI NR (non-redundant)
nucleotide sequence database using BLAST in order to identify
the potential Cdc42 target proteins that they encoded. Of the 325
sequences, 247 matched to existing database entries (known
proteins), while 46 were novel sequences not present in the
database. Of the remainder, four matched to uncharacterized
cDNA, two to RPCI-11 BAC library clones, 11 to chromosomal
regions, five to repetitive sequences and 10 were found to be false
positives. Interestingly the brain library yielded the largest
proportion of clones (Fig. S1 (i)) with many known Cdc42
interactors represented. Among the positive interactors were
known Cdc42 binding partners that contain CRIB (Cdc42/Rac-
interactive binding) motifs, such as N-WASP (14 clones from brain
library), ACK1 (Cdc42-activated tyrosine kinase 1; six clones from
brain library) and PAK2 (p21-activated kinase 2; five clones from
11-day embryo, heart and testis libraries), as well as known Cdc42
interactors that contain CRIB-like motifs, such as IRSp58 (50
clones from brain library), Par6 (par-6 partitioning defective 6
homolog alpha; 15 clones from brain and testis library), IRSp53
(12 clones from brain, fetal brain, kidney, liver and testis libraries;
[22]) and Cdc23 (cell division cycle protein 23; four clones from
brain and testis libraries; [23]).
Sixty-one clones encoded a total of 26 proteins not previously
known to bind to Cdc42 (Table S1). The most interesting
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that none of them has any CRIB or CRIB-like moiety. Eleven of
the sequences were represented by more than one clone from the
same library, such as PARIS-1 (prostate antigen recognized and
identified by SEREX 1; five clones from brain library), cAMP-
dependent protein kinase regulatory subunit RI-b (five clones each
from brain library), membrane-associated guanylate kinase p55
subfamily member 5 (four clones from liver library), PRKRA
(protein kinase, interferon-inducible double stranded RNA-
dependent activator; three clones from brain library), BRMS1-
like (breast cancer metastasis-suppressor 1-like; three clones from
brain library), and APC (two clones from the brain library). Three
of the sequences were represented by one or more clones from
more than one type of cDNA library, such as RanBP9 (four clones
from fetal brain, three clones each from ovary and testis and one
clone from kidney libraries), FHOD1 (three clones from bone
marrow and one each from kidney and testis libraries), myosin 9A
(three clones from ovary and one clone each from fetal brain and
liver libraries). The interaction of Cdc42 with FHOD1 and
RanBP9 was subsequently confirmed by further experiments
(unpublished data).
Selected clones from the brain and testis libraries encoding 10
putative novel Cdc42 interactors and one known Cdc42 binding
partner were purified and used in complementation assays with
Cdc42 to confirm the interactions in a clean yeast background.
Among the clones was one of two identical clones encoding a 431 aa
fragment of APC (APC
222–653) that was found to interact with Cdc42
in the Y2H library screens. The exact location of the clone within the
APC cDNA is shown in Fig 1. N-WASP, a known interactor of
Cdc42, was included as a positive control, and bait and prey vectors
lacking any inserts were used as negative controls. Matings for all
clones yielded diploids that formed colonies with a consistent pattern,
with the number of colonies decreasing with increasing stringency of
the selection medium (QDO being the most stringent, and leucine-
Figure1.StructureofAPCanditsinteractingconstructs. Schematic domain structure of APC describing binding sites with interacting partners.
(a) Full-length APC (b) APC
1–1638 and gene structure covering the yeast two-hybrid clone (c) Yeast two-hybrid clone, APC
222–653 (d) APC
222–453
construct without armadillo repeats (e) APC
453–653 construct with only armadillo repeats.
doi:10.1371/journal.pone.0016603.g001
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222–653 in vitro. (i) Cdc42-interacting APC clone from the brain cDNA library. The b-galactosidase
activity of different bait and prey pairs in the Y2H screen. (a) Cdc42/N-WASP (positive control), (b) Cdc42/APC, (c) Cdc42/pACT2 (negative control) and
(d) pAS2-1/N-WASP (negative control). (ii) Affinity pulldown assay. IRSp53 (positive control), GFP (negative control) and APC
222–653 were transcribed
and translated using the TNT T7 coupled reticulocyte lysate systems kit in the presence of
35S-methionine. The translated products were incubated
with GST-tagged Cdc42V12 or Cdc42N17 or GST bound to glutathione-sepharose beads. The protein complexes were eluted by boiling and resolved
by SDS-PAGE and detected by autoradiography. (a) Input for IRSp53, GFP and APC
222–653 respectively and (b) pulldowns using different affinity
columns. First two lanes are Cdc42V12 pulldowns of
35S-IRSp53 and




222–653 interaction with Cdc42V12 as shown by AP-FRET. mRFP-APC
222–653 and GFP-Cd42V12 were
coexpressed in CHO cells and AP-FRET analysis was carried out in the ROI (box). ROI line graphs showing the FRET assay results are shown below the
image. Scale bar=5mm. (iv) AP-FRET controls. AP-FRET analysis was carried out in the ROI (box). Line graphs showing the FRET assay results are shown
on the right of the respective panels. (a) cell expressing cytosolic GFP-mRFP, a tandem fusion serving as positive control, (b) cell coexpressing
cytosolic GFP and mRFP serving as negative control and (c) cell coexpressing mRFP-APC
222–653 and GFP-Cdc42N17. Scale bar=5 mm. (v) Table shows
the %FE and CC values of various APC constructs in the presence of (Cdc42V12, Cdc42N17, Rac1 or RhoA) along with positive and negative controls.
Data is shown as 6 SD, with three experiments and n=7–10 cells for each experiment.
doi:10.1371/journal.pone.0016603.g002
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formed diploids that grew on SD medium lacking leucine and
tryptophan but not on QDO medium (Fig. S1 (ii)). Diploids derived
from the remaining clones survived on QDO medium (Fig. S1 (ii)). b-
galactosidase assays were done to verify the results of the
complementation assays. Colonies derived from the positive control
N-WASP turned bright blue (Fig. 2(i), a) and were given color
intensity scores of (+++++) while those arising from negative controls
remained pale and were given a color intensity score of (+)( F i g .2 ( i ) ,c
and d). APC
222–653 gave rise to colonies that grew on QDO medium
and turned blue in the b-galactosidase assay with color intensity
scores of (+++++) similar to that obtained for the positive control
(Fig. 2(i), b). This shows that the Cdc42-APC binding is comparable
to that of Cdc42-N-WASP, and supports the view that Cdc42
interacts directly with APC
222–653. We further investigated the
interaction between Cdc42 and APC in this study.
APC is large protein comprising 2843 aa and multiple protein
binding sites. The APC Y2H clone ends in intron 14 and possesses
a polyA tail. It is possible that the human brain cDNA used to
make the library was from an individual who had a truncation
mutation in intron 14 of the APC gene, allowing it to be
represented. The sequence of the APC clone encodes three full
armadillo repeats (453–653 aa) and some N-terminal flanking
sequences (222–453 aa). To confirm that Cdc42 did indeed
interact with APC
222–653, we carried out affinity pulldown
experiments using an in vitro transcription/translation system.
35S-labelled IRSp53 (positive control), GFP (negative control) and
APC
222–653 (experimental) were incubated with purified GST,
GST-Cdc42V12 or GSTCdc42N17 fusion protein. Cdc42N17 is a
dominant negative mutant that remains GDP-bound and interacts
with effectors weakly if at all. The data shown in Fig. 2 (ii) confirms
that Cdc42V12 but not Cdc42N17 interacts with APC
222–653 and
IRSp53.
Next we used AP-FRET [18] to examine whether Cdc42
interacts with APC
222–653 in vivo. Briefly, in order to carry out AP-
FRET, fusion proteins of interacting pairs were made by linking
the donor-acceptor pair of fluorescent proteins. In this case GFP
served as the donor while mRFP was used as the acceptor. cDNA
encoding GFP-Cdc42V12 and mRFP-APC
222–653 was cotrans-
fected into CHO cells and allowed to express for 24 h. An ROI
was chosen, and pre-bleach images acquired. Bleaching was then
carried out and images acquired during the bleaching process.
Changes in intensity of GFP and mRFP were monitored during
pre- and post-bleach and plotted in Fig. 2 (iii). FRET occurs if
donor (GFP) intensity increases on acceptor (mRFP) bleaching.
The background subtracted intensities were used for FRET
calculations. For AP-FRET analysis the change in GFP intensity
after mRFP bleaching is expressed as %FE. In addition we
determined a CC value for the rates of change in GFP and mRFP
intensities on bleaching of mRFP. There should be a negative CC
value when FRET occurs. Positive FRET is indicated by a FRET
efficiency of .3% and CC.20.7 (see [18] for complete
explanation of the rationale behind AP-FRET). Further, CC values
are only considered if %FE is above 3%. The intensity plot of AP-
FRET for controls is given in Fig. 2 (iv). The average results of AP-
FRET with Cdc42V12 or Cdc42N17 and mRFP-APC
222–653 along
with that of unfused GFP/mRFP pairs, and the tandem GFP-
mRFP construct (that were used as controls to set the limits for
negative and positive FRET respectively) are given in Fig. 2 (v).
Cdc42V12with mRFP-APC
222–653gavea%FEof13.9%andaCC
value of 20.97, indicating positive FRET. In contrast, when
Cdc42N17 was used in place of Cdc42V12, the corresponding
valueswere1.7%and 20.1respectively, suggestingno FRET.Thus
three independent methods, yeast two-hybrid, affinitypulldown and
FRET show that Cdc42 interacts directly with APC
222–653.I n
addition, the FRET analysis shows that mRFP-APC
222–653 interacts
weakly with Rac1 but not with RhoA (Fig. 2, panel (v)). Taken
together, these results suggest that Cdc42 interacts specifically with
APC.
To further understand the role that the sequence in front of the
armadillo repeats within APC
222–653 plays in Cdc42 interaction,
we made two shorter constructs: one without the armadillo repeats
(APC
222–453) and the other with only the armadillo repeats of
APC
222–653 (APC
453–653), both tagged with mRFP. Fig. 2 (v) shows
data from experiments carried out to evaluate AP-FRET between
Cdc42V12, APC
222–453 and APC
453–653. With Cdc42 and
APC
222–453, the data do not satisfy the criteria for positive FRET
as the %FE is below 3%. In contrast, the %FE is 7.0% with
APC
453–653, suggesting that the sequences within residues 222–453
are necessary but not sufficient for Cdc42V12 binding. Thus the
full sequence of the APC
222–653 fragment found in the Y2H screen
is necessary for a strong Cdc42 interaction.
Cdc42 interacts with APC and APC
1–1638
It is difficult to express full-length APC in many cell types
because of its large size and its role in cell cycle arrest [24]. We
Figure 3. Localization and interaction of GFP-APC, GFP-APC
1–1638 with Cdc42V12 or Cdc42N17. (i) APC localization in CHO cells. Images
showing the expression and distribution of exogenous GFP-APC, GFP-APC
1–1638 and mRFP-Cdc42V12. The enlarged image of the box in the mRFP-
Cdc42V12 panel is shown on the right. This pseudo-colored image shows mRFP-Cdc42V12 localization in lamellipodia (arrow heads). Scale bar=5mm.
(ii) Cdc42V12 interacts directly with GFP-APC and GFP-APC
1–1638 (only the leading edges of CHO cells are shown). The line graphs on the right of the
images show the FRET intensity analysis. Image processing was done by applying a low pass filter in Metamorph software to subtract out-of-focus
blur. (a) Cells coexpressing mRFP-Cdc42V12 and GFP-APC. AP-FRET was carried out in the ROI at the cell edges (box). Images in the top row show the
pre-bleach data and those in the bottom row show post-bleach data. (b) Cell coexpressing mRFP-Cdc42V12 and GFP-APC
1–1638. FRET analysis was
carried out with vesicles as shown by the ROI. The top and bottom rows show the pre- and post-bleach images respectively. Scale bar=5mm. (iii)
FLIM-FRET images of GFP-APC and GFP-APC
1–1638 in CHO cells. The top row shows the FLIM image of (a) GFP-APC, (b) GFP-APC and mRFP-Cdc42V12
coexpression, (c) GFP-APC
1–1638 and (d) GFP-APC
1–1638 and mRFP-Cdc42V12 coexpression. The respective intensity image (e–h) of each FLIM image is
given in the bottom row. (iv) FLIM-FRET control images. FLIM images of CHO cells showing cytosolic GFP, cytosolic GFP/mRFP coexpression (negative
control) and cytosolic GFP-mRFP tandem fusion (positive control). The intensity image of the respective FLIM image is shown in the bottom panel. (v)
Table describing the average lifetime data of GFP fusion proteins in the absence and presence of mRFP-Cdc42V12 or Cdc42N17 in CHO cells. Data is
shown as average lifetime 6 SD from three experiments with n=8–15 for each experiment. (vi) Table showing percentage FLIM-FRET efficiency CC
values of APC and APC
1–1638 in presence of Cdc42V12 or Cdc42N17 along with positive and negative controls. Data is shown as 6 SD, with three
experiments and n=7–10 cells for each experiment. (vii) Cdc42 co-immunoprecipitation assay for endogenous APC in SW480 cells. SBP was used as
an affinity tag for pulldown. cDNA encoding mRFP-SBP-GFP (negative control) or mRFP-SBP-Cdc42V12 (experimental) were separately transfected
into SW480 cells and allowed to express for 24 h. After cell lysis (see Materials and Methods for details) streptavidin-sepharose beads were used to
pull down SBP-tagged fusion proteins. Proteins were then resolved by SDS-PAGE and transferred to PVDF membranes. The blots were probed for APC
protein using APC antibody (Ab-5 from Calbiochem) and subsequently stripped and reprobed with streptavidin-HRP antibody to assess amounts of
mRFP-SBP-GFP and mRFP-SBP-Cdc42V12.
doi:10.1371/journal.pone.0016603.g003
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PLoS ONE | www.plosone.org 8 February 2011 | Volume 6 | Issue 2 | e16603found that CHO cells were a good system for this study as APC
expressed well in these cells and allowed us to follow the
localization of the protein. When expressed individually in CHO
cells, mRFP-Cdc42V12, GFP-APC and GFP-APC
1–1638 had
distinct cellular distribution patterns (Fig. 3(i)). Full-length GFP-
APC is more concentrated in the microtubule ends (Fig. S2;
Dikovskaya et al. and see [25] for a review on APC localization)
and throughout the cell. In contrast to full-length APC, APC
1–1638
localized in cytoplasmic puncta as previously reported for the type
II mutants [9]. Unlike full-length APC, APC
1–1638 did not localize
to the nucleus and this is likely due to the lack of a C-terminal
nuclear localization sequence in the latter protein. mRFP-
Cdc42V12 was localized throughout the cell with most of it in
the nuclear and perinuclear area. In addition, Cdc42 expression
alone induced the formation of lamellipodia [26], but this structure
was not present in untransfected CHO cells. Previous studies have
reported that the majority of activated Cdc42 is localized to the
membrane rather than in the cytosol [27].
To determine whether Cdc42 could interact with more physiolog-
ically relevant versions of APC we carried out FRET experiments with
full-length APC and a truncation mutant linked with cancer, APC
1–1638.
Cdc42 AP-FRET experiments for both APC proteins are shown in
Fig. 3(ii) and Fig. 3(vi)). As suggested by the experiments showing that
Cdc42V12 interacts with APC
222–653, Cdc42V12 interacted with GFP-
APC in the cytoplasm and also at the leading edges of cells. In addition,
Cdc42V12 and GFP-APC
1–1638 interacted in puncta.
The AP-FRET data was further confirmed by performing
FLIM, a method where changes in the GFP fluorescence lifetime
[21] of the interacting donor molecule is measured. For FLIM we
used GFP and mRFP fusion proteins as donor-acceptor pairs. As
expected we observed changes in GFP fluorescence lifetime when
Cdc42 and APC pairs were examined (Fig. 3 (iii)). Results of
control experiments with cells transfected with either GFP-mRFP
fusion alone or cotransfected with unfused GFP and mRFP are
given in Fig. 3 (iv). We observed that GFP-APC had an average
lifetime of 2.460.12 ns (n=12), but when coexpressed with
mRFP-Cdc42V12 the lifetime of GFP-APC decreased to
2.060.03 ns (n=14). Similarly GFP-APC
1–1638 alone had a
lifetime of 2.260.14 ns (n=14), within the puncta, whereas
coexpression with mRFP-Cdc42 shortened its lifetime to
1.860.16 ns (n=11). The difference in lifetime observed with
the expression of GFP-APC and GFP-APC
1–1638 alone could be
attributed to the refractive index of its environment [28]. The
coexpression of mRFP-Cdc42N17 had a smaller effect on the GFP
fluorescence lifetimes of APC and APC
1–1638. The average GFP
fluorescence lifetime of transfected cells with and without
cotransfection of Cdc42 mutants are given in table (Fig. 3 (v)).
The percentage FLIM-FRET efficiency (see Materials and
Methods for details) was calculated for the respective interactions
and is given in (Fig. 3 (vi)). Importantly, both AP-FRET and
FLIM-FRET show that Cdc42 interacts directly with APC and
APC
1–1638 when coexpressed together.
Cdc42V12 induces translocation of GFP-APC
1–1638 to the
golgi-lysozome pathway
To determine the nature of the puncta where GFP-APC
1–1638
was localized to, we used the following markers of membrane
compartments: Rab5, Rab7, GM130, Rab11, Lamp1, mitotracker,
caveolin-mRFP, and transferrin red. Quantitative colocalization of
GFP-APC
1–1638 with these markers was carried out with both line
intensity and ROI. GFP-APC
1–1638 did not colocalize with any of
these markers (Fig. 4 (iii)). However, in some cells GFP-APC
1–1638
did show a partial colocalization with the golgi marker GM130. In
the presence of Cdc42V12, APC
1–1638 puncta are colocalized with
GM130 (Fig. 4 (i)) and the lysozome marker Lamp1 (Fig. 4 (ii)),
suggesting that Cdc42 influences GFP-APC
1–1638 localization. The
ROI colocalization analysis allows quantification of the colocaliza-
tion by deriving a Pearson correlation coefficient (CC*) value. For
GFP-APC
1–1638 and GM130 marker in the presence of Cdc42V12,
the CC* value was 0.6660.14 (n=7). Similarly the CC* value for
Lamp1 and GFP-APC
1–1638 in the presence of Cdc42V12 was
0.8460.06 (n=10). These results suggest that Cdc42 stimulates the
GFP-APC
1–1638 to enter a trafficking pathway that may lead to its
degradation. Endogenous Cdc42 has previously been shown to
localize to the golgi apparatus [29].
Cdc42 induces translocation of GFP-APC to F-actin sites
at the leading edge
In control untransfected CHO cells, most of the F-actin was in
the form of stress fibers, with some also at the leading edge (Fig. 5 (i)
panel a). When Cdc42V12 was expressed in CHO cells, membrane
ruffles and lamellipodia were seen at the leading edge and stress
fibers were reduced (Fig. 5(i) panel d). When GFP-APC was
expressed on its own it had no effect on actin distribution (Fig. 5(i)
panel b and f). While GFP-APC expressing cells appeared to show a
decrease in stress fibers, a careful analysis of cells (n=7) in the
absence and presence of GFP-APC revealed that there was no
reduction in stress fibers. When GFP-APC was coexpressed with
Cdc42V12 in CHO cells, F-actin was seen at the leading edge,
although this was not as pronounced as in the case of Cdc42V12
alone; membrane ruffling also appeared to be reduced (Fig. 5 (i)
panel c). Interestingly, Cdc42V12 induced APC to localize to the
leading edge, whereas Cdc42N17 did not (Fig. 5 (i), compare panels
c and e). Using line intensity analysis we found that GFP-APC only
colocalized with F-actin at the leading edge in the presence of
Cdc42V12 (Fig. 5(i) panel g). Next we carried out a quantitative
ROI analysis of GFP-APC with F-actin in the presence of
Cdc42V12. GFP-APC and F-actin colocalized with a CC* value
of 0.8760.05 (n=4). This suggests that APC is localized at the
leading edges of cells along with actin in the presence of Cdc42.
Effect of Cdc42 on endogenous APC proteins in colon
cancer cell lines
To examine the effect of Cdc42V12 on APC localization in a
more physiological contextwedecided tostudythesetwoproteinsin
Figure 4. Colocalization of APC
1–1638 in the absence and presence of Cdc42V12 with endocytic markers in CHO cells. (i) Cells were
stained for golgi with GM130 primary and Alexa 405-tagged secondary antibodies. (a) Cells coexpressing GFP-APC
1–1638 and mRFP-Cdc42V12, (b) cells
expressing GFP-APC
1–1638 (control), (c) cells coexpressing GFP-APC
1–1638 and mRFP-Cdc42N17. The arrows mark positions for possible colocalization.
Colocalization analysis was carried out along the white dotted lines as shown on the images. (d) Line intensity colocalization analysis of GFP-APC
1–
1638 and Cdc42V12 in the cell shown in (a). (e) Line intensity colocalization analysis of GFP-APC
1–1638 and GM130 in the cell shown in (b). (ii) Cells were
stained for lysozomes and Cdc42 using Lamp1 and anti-HA primary antibodies and Cy 5 and Alexa 405 secondary antibodies respectively. (a) Cells
coexpressing GFP-APC
1–1638 and HA-Cdc42V12, (b) cells expressing GFP-APC
1–1638 (control) and (c) cells coexpressing GFP-APC
1–1638 and HA-
Cdc42N17. The arrows in (b) and (c) mark positions for possible colocalization. Colocalization analysis was carried out along the white dotted lines
shown on the images. (d) Line intensity colocalization analysis of GFP-APC
1–1638 and HA-Cdc42V12 in the cell shown in panel (a). Scale bar=5mm. (iii)
Table showing details of markers tested for GFP-APC
1–1638 in the absence (first column) and in the presence of Cdc42V12 (second column). The plus
sign shows the extent of colocalization with 2 being absent, ++ being the lowest and +++++ the highest.
doi:10.1371/journal.pone.0016603.g004
Cdc42 Interacts Directly with APC Protein
PLoS ONE | www.plosone.org 9 February 2011 | Volume 6 | Issue 2 | e16603two colon cancer cell lines. HCT116 cells express full-length APC
while SW480 cells express a truncated form of APC (APC
1–1338)
endogenously. When we expressed mRFP-Cdc42V12, it induced
the translocation of full-length APC to the leading edge in HCT116
cells as seen by a line intensity analysis (Fig. 5(ii) panels a, b and e)
but mRFP-Cdc42N17 did not (Fig. 5(ii) panel d). Furthermore, a
quantitative ROI analysis gave a CC* value of 0.9560.12(n=8) for
Cdc42V12 and endogenous APC. To rule out the possibility that
relocalization of APC to the leading edge was due to GSK-3b
mediated phosphorylation via the Cdc42-Par3/Par6/PKC path-
way rather than direct interaction with Cdc42, we used a GSK-3b
inhibitor (cell permeable PKCf–specific pseudosubstrate) [19]. The
GSK-3b inhibitor did not influence the Cdc42-induced transloca-
tion of APC to the leading edge (Fig. 5 (ii) panels c and f). The CC*
value for Cdc42V12 and APC in the presence of GSK-3b inhibitor
was 0.8760.04 (n=8).
Next we investigated the effect of Cdc42V12 on localization of
endogenous APC proteins expressed in HCT116 cells and SW480
cells with actin in the presence of Cdc42V12 or Cdc42N17. In
HCT116 cells, actin and APC were found to colocalize at the
leading edge in presence of Cdc42V12 as shown by line intensity
analysis (Fig. 5(iii) panels a and c), whereas in the presence of
Figure 5. Leading edge localization of APC and Cdc42V12. (i)
APC and Cdc42V12 colocalize with actin at the leading edges in CHO
cells. Cells were stained with TRITC-phalloidin for actin and anti-HA for
Cdc42 with Alexa 405-tagged secondary antibody. (a) untransfected
CHO cell, (b) cell expressing GFP-APC, (c) cell coexpressing GFP-APC and
HA-Cdc42V12, (d) cell expressing mRFP-Cdc42V12 and (e) cell
expressing GFP-APC and HA-Cdc42N17. Image processing for leading
edge localization was done using ImageJ software. Colocalization
analysis was carried out along the white dotted lines as shown on the
images. (f) Line intensity colocalization analysis of GFP-APC and TRITC-
phalloidin of the cell shown in panel (b) and (g) line intensity
colocalization analysis of GFP-APC, HA-Cdc42V12 and TRITC-phalloidin
of the cell shown in panel (c). Scale bar=5 mm. (ii) Endogenous APC
colocalizes with Cdc42V12 at the leading edges in HCT116 cells. (a) Cell
stained for endogenous APC with anti-APC primary antibody (ab-2) and
Alexa 488-tagged secondary antibody, (b) cell expressing mRFP-
Cdc42V12 and stained for endogenous APC, (c) mRFP-Cdc42V12
expressing cell was treated with GSK-3b inhibitor (cell-permeable PKC
f–specific pseudosubstrate) followed by immunostaining for APC, (d)
cell expressing mRFP-Cdc42N17 stained for endogenous APC. Image
processing for leading edge localization was done by applying a low
pass filter in Metamorph software to subtract out-of-focus blur.
Colocalization analysis was carried out along the white dotted lines
shown on the images. (e) Line intensity colocalization analysis of
endogenous APC and mRFP-Cdc42V12 of the cell shown in panel (b)
and (f) line intensity colocalization analysis of endogenous APC and
mRFP-Cdc42V12 of the cell shown in panel (c). Scale bar=5mm. (iii)
Endogenous APC colocalization with GFP-actin in HCT116 cells in
presence of Cdc42V12 or Cdc42N17. (a) Cell coexpressing mRFP-
Cdc42V12 and GFP-actin. (b) Cell coexpressing mRFP-Cdc42N17 and
GFP-actin. Image processing for leading edge localization was done by
applying a low pass filter in Metamorph software to subtract out-of-
focus blur. Pseudo-coloring was applied using Metamorph software.
Colocalization analysis was carried out along the white dotted lines
shown on the images. (c) Line intensity colocalization analysis of stained
endogenous APC and GFP-actin of cell shown in panel (a). Scale
bar=5 mm. (iv) Endogenous APC colocalization with GFP-actin in
SW480 cells in presence of Cdc42V12 or Cdc42N17. (a) Cell coexpressing
mRFP-Cdc42V12 and GFP-actin, (b) cell coexpressing mRFP-Cdc42N17
and GFP-actin. Image processing for leading edge localization was done
by applying a low pass filter in Metamorph software to subtract out-of-
focus blur. Pseudo-coloring was applied using Metamorph software.
Colocalization analysis was carried out along the white dotted lines
shown on the images. (c) Line intensity colocalization analysis of stained
endogenous APC and GFP-actin of cell shown in panel (a). Scale
bar=5mm.
doi:10.1371/journal.pone.0016603.g005
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panel b). The quantitative ROI analysis gave a CC* value of
0.6060.01 (n=8) for APC and actin in presence of Cdc42V12.
However, in SW480 cells, APC and actin did not show any
colocalization at the leading edges, as evident from line intensity
analyses (Fig. 5(iv) panels a and c) in presence of Cdc42V12 or
Cdc42N17 (Fig. 5(iv) panel b). The quantitative ROI analysis of
SW480 cells gave a CC* value of 0.3360.10 (n=8) for APC and
actin. Only full-length endogenous APC localized to the leading
edge with actin in the presence of Cdc42V12.
Discussion
In this study we have carried out an extensive Y2H analysis of
nine tissue cDNA libraries using Cdc42 as a bait. In our Y2H
screensweidentified most oftheknownCdc42 interactors and these
include IRSp53, PAK isoforms, Cdc23, ACK1 and N-WASP. We
reconfirmed the Y2H results by purifying prey plasmids and
introducing them into fresh yeast cells and measuring growth on
QDO plates and b-galactosidase activity. Most importantly, we
identified APC as a Cdc42 target. For FHOD1 and RanBP9 we
have independent evidence that these proteins can bind Cdc42
(unpublished data). We believe all 10 novel partners interact
specifically with Cdc42. Further analysis will be required to confirm
this. Interestingly, with these 10 proteins we could not identify a
common motif or resemblance to known Cdc42-binding motifs
such as CRIB and HR1 and this may suggest novel Cdc42
interaction mechanisms. Our results suggest that Cdc42 affects a
wider range of signaling pathways than previously thought.
APC is a large multidomain 2834 aa scaffold protein having
interaction sites that take it to different cellular locations (for review
see [30]). APC has been detected in the nucleus, associated with
microtubules, actin-based membrane ruffles, actin-dependent cell-
cell junctions, plasma membranes, mitochondria, growth cones and
centrosomes. APC interaction partners that are known to help
localize it include EB1 and Asef/IQGAP [2,4,5]. The latter two
proteins associate with the APC armadillo repeats. Interestingly, in
an exciting recent study, APC has been found to localize RNAs to
cell protrusions [31]. Thus it may be the case that the Cdc42
interaction with APC helps this RNA-localization function of APC.
Cdc42V12 interacted with APC in vitro, as shown by Y2H
experiments and affinity pull down, and in vivo,a ss h o w nb yA P -
FRET and FLIM. This is very strong evidence that Cdc42 can
directly bind to APC. Cdc42V12 interacts directly with the armadillo
repeats of APC
222–653, thus both full-length and truncation mutants
(e.g. APC
1–1638) will be targets. Cdc42V12 was found to relocate full-
length APC from microtubule ends to the leading edge along with F-
actin. We showed for both exogenously and endogenously expressed
APC that Cdc42V12 can affect its cellular distribution. The direct
Cdc42-APC interaction, along with the Cdc42-Par3/Par6 complex,
may well be necessary for cell polarity decisions. In animal models the
APC truncation mutant APC
1–1638 increases tumor susceptibility.
APC
1–1638 neither binds actin nor colocalizes with it. With the APC
truncation mutant APC
1–1638, Cdc42V12 induced a cellular
redistribution to the golgi and lysozome compartments. Thus
Cdc42 may lead to degradation of APC mutants and this may
potentiallyincreasethetumorsusceptibilityofthe cells.TheFRETor
FLIM results also give spatial information on the Cdc42-APC
interaction and this highlights the physiological significance of the
analysis. Thus our conclusion is that the physiological function of
Cdc42 interaction with APC serves to localize full length APC to the
leading edge with F-actin and with APC
1–1638 to the golgi/lysozome
compartments. Future work with APC mutants that cannot bind
C d c 4 2w i l lh a v et ob ed o n et of u r t h e re x p l o r et h ep h y s i o l o g i c a l
function of the Cdc42-APC interaction.
In preliminary experiments, we have found that Cdc42 and Asef
compete with each other to bind APC (unpublished data). This could
suggest that the APC-Asef interaction serves to activate Cdc42 near
APC, and once activated, Cdc42 can bind APC, directing it to the
leading edge with F-actin. Understanding the link between APC and
the actin cytoskeleton would be a major step forward in
understanding the biology of APC and its tumor suppressor activity.
The well studied APC binding proteins linked to the actin machinery
areAsefandIQGAP1.APCmayalsobeassociatedindirectlytoactin
through beta-catenin. However, CHO cells lack any endogenous or
detectable levels of IQGAP, Cdc42 or beta-catenin [32–34]. Cdc42
induced localization of APC to F-actin at the leading edge was
insensitive to the GSK-3b inhibitor suggesting that the direct
interaction of Cdc42 with APC is important. In addition Dikovskaya
[25] have suggested that microtubule binding of APC via the basic
domain is regulated by other regions of the molecules in full-length
APC. Consistent with this idea our data support the proposed role of
Cdc42 binding at the N-terminus of APC, linking it to F-actin and
localization it to the leading edge. Cdc42 affected the localization of
transfected APC in CHO cells, and endogenous APC in SW480 and
HCT116 cells, suggesting that Cdc42-APC interactions have roles in
both normal physiology and tumorigenesis.
RhoGTPases are linked to cancer progression and have
documented roles in cell invasiveness and metastasis [35,36]. It
has been reported that in epithelial cells the disruption of polarity
caused cell invasion into the surrounding environment [37]. Cdc42
hasanimportantroleincellpolarity,perhapsthroughitsinteraction
with APC and actin at the leading edge [19]. Selective
depolarization of basolateral membrane proteins by functional
deletion of Cdc42 leads to inhibition of membrane traffic to the
basolateral plasma membrane in both the endocytic and secretory
pathways [38]. Further work investigating Cdc42 interaction with
APC and its mutants on SW480 cells will likely reveal novel insights
into the biology and cancer-causing abilities of these proteins.
Supporting Information
Figure S1 Y2H library screens. (i) The pie chart shows the
proportion of Cdc42-interacting clones obtained in cDNA libraries
derived from nine different tissues. The cDNA libraries were
screened using Cdc42Q61L/C189S as bait. (ii) The table shows
growth on selection media and b-galactosidase activity of clones in
Y2H complementation assays. Prey plasmid DNA encoding
putative Cdc42 interactors was purified from the positive clones
and co-transformed with bait plasmids into a fresh yeast
background to confirm interactions. Data from human brain
and testis libraries are presented. In total 14 clones were analyzed,
including a known interactor, 10 novel clones and 3 controls.
Numbers shown are of colonies detected with the different bait/
prey pairs under different selection conditions. The plus sign shows
the intensity of X-gal staining (b-galactosidase activity) with +
being the lowest intensity and +++++ the highest.
(TIF)
Figure S2 GFP-APC colocalizes with a-tubulin. CHO cells
transfected with GFP-APC were stained for a-tubulin using mouse
anti a-tubulin primary antibody and anti-mouse Alexa 568-tagged
secondary antibody. Scale bar=5mm.
(TIF)
Table S1 Yeast two-hybrid identification of putative
novel Cdc42 interactors. Sequences from 61 clones were
Cdc42 Interacts Directly with APC Protein
PLoS ONE | www.plosone.org 11 February 2011 | Volume 6 | Issue 2 | e16603matched with entries using BLAST and found to encode a total of
26 putative novel Cdc42 interactors not previously known to bind
Cdc42 in the NCBI non-redundant nucleotide sequence database.
Of these, 11 were represented by more than one clone, and 3
represented by clones from more than one type of cDNA library.
(DOC)
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